Posted inClinical Updates General Surgery Oncology
Primary Tumor Biology Predicts Recurrence and Survival Outcomes After Colorectal Liver Metastasis Resection: Insights from the BIO-CRLM Study
The BIO-CRLM study demonstrates that integrating primary tumor location with RAS/BRAF mutation status defines distinct recurrence patterns and survival outcomes after colorectal liver metastasis resection, enabling improved prognostication and personalized patient management.
